Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC

This international, peer-reviewed Open Access journal by Dove Medical Press focuses on the design and development of drugs, as well as the clinical outcomes, patient safety, and programs targeted at the effective and safe use of medicines. Sign up for email alerts here.

88,007 Monthly downloads/views I 4.319 Impact Factor I 6.6 CiteScore I 1.12 Source Normalized Impact per Paper (SNIP) I 0.784 Scimago Journal & Country Rank (SJR)

Record: found
Abstract: found
Article: found

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC

Author(s): Akito Natsume

Publication date (Electronic): December 2008

Journal: Drug Design, Development and Therapy

Publisher: Dove Medical Press Ltd.

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Author and article information

Journal

Title: Drug Design, Development and Therapy

Abbreviated Title: DDDT

Publisher: Dove Medical Press Ltd.

ISSN (Electronic): 1177-8881

Publication date (Electronic): December 2008

Page: 7

Article

DOI: 10.2147/DDDT.S4378

SO-VID: e73c90d0-5131-4443-9e47-04075a6a299f

History

Data availability:

Comments

Comment on this article

scite_